MARK L. PERRY

Insider Reports History

Location
Mill Valley, CA
Signature
/s/ Rebecca Peters, Attorney-in-Fact for Mark L. Perry
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by MARK L. PERRY:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NVIDIA CORP Director Common Stock 116K $103M $887.89 02 Apr 2024 By Trust
NVIDIA CORP Director Common Stock 13.6K $12.1M $887.89 02 Apr 2024 Direct
NVIDIA CORP Director Common Stock 1K $888K $887.89 02 Apr 2024 The Taylor William Perry 2023 Irrevocable Trust
NVIDIA CORP Director Common Stock 1K $888K $887.89 02 Apr 2024 The Zoe Blue Perry 2020 Irrevocable Trust
Global Blood Therapeutics, Inc. Director Common Stock 0 $46.99 05 Oct 2022 Direct
Global Blood Therapeutics, Inc. Director Restricted Stock Units 0 05 Oct 2022 Direct
Global Blood Therapeutics, Inc. Director Stock Option (Right to Buy) 0 05 Oct 2022 Direct

Insider Reports Filed by MARK L. PERRY

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NVDA NVIDIA CORP 26 Jun 2024 0 $0 4 Director 26 Jun 2024, 16:14
NVDA NVIDIA CORP 02 Apr 2024 1 -$6.22M 4 Director 03 Apr 2024, 16:27
NVDA NVIDIA CORP 23 Feb 2024 1 -$11.9M 4 Director 27 Feb 2024, 17:06
NVDA NVIDIA CORP 23 Jun 2023 1 $0 4 Director 27 Jun 2023, 18:24
NVDA NVIDIA CORP 26 May 2023 3 $0 4 Director 31 May 2023, 17:15
NVDA NVIDIA CORP 27 Feb 2023 4 -$4.73M 4 Director 28 Feb 2023, 15:59
GBT Global Blood Therapeutics, Inc. 05 Oct 2022 7 $0 4 Director 06 Oct 2022, 16:21
GBT Global Blood Therapeutics, Inc. 14 Jun 2022 4 $0 4 Director 16 Jun 2022, 18:38
NVDA NVIDIA CORP 03 Jun 2022 1 $0 4 Director 07 Jun 2022, 18:16
NVDA NVIDIA CORP 18 Mar 2022 4 -$4.41M 4 Director 21 Mar 2022, 18:16
GBT Global Blood Therapeutics, Inc. 17 Jun 2021 4 $0 4 Director 21 Jun 2021, 16:27
NVDA NVIDIA CORP 04 Jun 2021 1 $0 4 Director 08 Jun 2021, 16:10